Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1999-10-18
2000-08-22
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 179, A61K 3170
Patent
active
061072826
ABSTRACT:
This invention relates to prevention and/or treatment of antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD), pseudomembranous colitis (PMC) and other conditions associated with C. difficile infection, using oligosaccharide compositions which bind C. difficile toxin B. More specifically, the invention concerns neutralization of C. difficile toxin B associated with such conditions.
REFERENCES:
patent: 4137401 (1979-01-01), Lemieux et al.
patent: 4238473 (1980-12-01), Lemieux et al.
patent: 4362720 (1982-12-01), Lemieux et al.
patent: 5079353 (1992-01-01), Ratcliffe et al.
patent: 5484773 (1996-01-01), Heerze et al.
patent: 5635606 (1997-06-01), Heerze et al.
patent: 5637576 (1997-06-01), Heerze et al.
patent: 5767093 (1998-06-01), Good et al.
patent: 5817633 (1998-10-01), Heerze et al.
Abbas, S.A., et al., "Tumor-Associated Oligosaccharide I: Synthesis of Sialyl-Lewis.sup.a Antigenic Determinant", Sialic Acids, Proc Japan-German Symp Berlin, 22-23 (1988).
Amvam-Zollo, P., et al., "Streptococcus pneumoniae Type XIV Polysaccharide: Synthesis of a Repeating Branched Tetrasaccharide with Dioxa-Type Spacer-Arms", Carbohy Res, 150:199-212 (1986).
Armstrong, G.D., et al., "Investigation of shiga-like toxin binding to chemically synthesized oligosaccharide sequences", J Infect Dis, 164:1160-7 (1991).
Barbut, F., et al., "Comparison of Enterotoxin Production, cytotoxin production, serogrouping and antimicrobial susceptibilities of clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients", J Clin Microb, 31:740-2 (1993).
Bartlett, J.D., "Treatment of antibiotic-associated pseudomembranous colitis", Rev Infect Dis, 6(Suppl 1): S235-41 (1984).
Bartlett, J.G., et al., "Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia", N Engl J Med, 298:531-534 (1978).
Bartlett J.G., "Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism", Clin Infect Dis, 18(Suppl 4):S265-272 (1994).
Bartlett, J.G., et al., "Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis", Gastroent, 78:431-4 (1989).
Chang, T.W., et al., "Inhibition of binding of Clostridium difficile toxin by steroids", J Infect Dis, 142:113 (1980).
Chernyak, A.Y., et al., "A New Type of Carbohydrate-Containing Synthetic Antigen: Synthesis of Carbohydrate-Containing Polyacrylamide Copolymers having the Specificity of 0:3 and 0:4 Factors of Salmonella", Carbohy Res, 128:269-282 (1984).
Clark, G.F., et al., "Toxin A from Clostridium difficile binds to rabbit erythrocyte glycolipids with terminal .alpha.Gal(1-3).beta.Gal(1-4).beta.GlcNAc sequences", Arch Biochem Biophys, 257:217-29 (1987).
Cox, D., et al. "A New Synthesis of 4-0-.alpha.-D-Galactopyranosyl-D-Galacto-Pyranose", Carbohy Res, 62:245-252 (1978).
Cozart, J.C., et al., "Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Method of treatment and clinical response to treatment", J Clin Gastroent, 16:192-4 (1993).
Dhamen, J., et al., "2-Bromoethyl glycosides: applications in the synthesis of spacer-arm glycosides," Carbohy Res, 118:292-301 (1983).
Dahmen, J., et al., "Synthesis of space arm, lipid, and ethyl glycosides of the trisaccharide portion [.alpha.-D-Gal-(1-4)-.beta.-D-Gal(1-4)-.beta.-D-Glc] of the blood group p.sup.k antigen: preparation of neoglycoproteins", Carbohy Res, 127:15-25 (1984).
Donta, S.T., et al., "Differential effects of Clostridium difficile toxins on tissue-cultured cells," J Clin Microb, 15:1157-1158 (1982).
Ekborg, G., et al., "Synthesis of Three Disaaccharides for the Preparation of Immunogens bearing Immunodeterminants Known to Occur on Glycoproteins", Carbohy Res, 110:55-67 (1982).
Fernandez-Santana, V., et al., "Glycosides of Monoallyl Diethylene Glycol. A New type of Spacer group for Synthetic Oligosaccharide", J Carbohy Chem, 8(3):531-537 (1989).
Finegold, S.M., et al., "Therapy directed against Clostridium difficile and its toxins. Complications of therapy". In Rolfe, R.D.,etal., (eds) C. difficile: It's Role in Intestinal Disease, Academic Press, Inc, San Diego, CA, 341-57 (1988).
Fiorentini, C., et al., "Clostridium difficile toxin A and its effect on cells," Toxicon, 29:543-567 (1991).
Flegel, W.A., et al., "Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B," Infect Immun, 59:3659-3666 (1991).
Fugedi, P., et al., "Thioglycosides as Glycosylating Agents in Oligosaccharide Synthesis", Glycoconjugate J, 4:97-108 (1987).
Garegg, P.J., et al., "A Synthesis of 8-Methoxycarbonyloct-1-yl O-.beta.-D-Galactopyranosyl-(1.fwdarw.3)-0-.beta.-D-Galactopyranosyl-(1.fw darw.4)-2-Acetamido-2-Deoxy-.beta.-D-Glucopyranoside", Carbohy Res, 136:207-213 (1985).
Garegg, P. J., et al., "Synthesis of 6- and 6' -deoxy derivatives of methyl 4-0-.alpha.-D-galactopyranosyl-.beta.-D-galactopyranoside for studies of inhibition of pyelonephritogenic fimbriated E. coli adhesion to urinary epithelium-cell surfaces", Carbohy Res, 137:270-275 (1985).
Heerze, L.D., et al., "Oligosaccharide sequences attached to an inert support (SYNSORB) as potential therapy for antibiotic-associated diarrhea and pseudomembranous colitis," J Infect Dis, 169:1291-1296 (1994).
Jacquinet, J.C., et al., "Synthesis of Blood-group Substances, Part 11. Synthesis of the Trisaccharide O-.alpha.-D-Galactopyranosyl-(1.fwdarw.3)-0-.beta.-D-galactopyranosyl-(1.f wdarw.4)-2-acetamido-2-deoxy-D-glucopyranose", J C S Perkin, 1:326-330 (1981).
Kameyama, A., et al., "Total synthesis of sialyl Lewis X", Carbohy Res, 209:c1-c4 (1991).
Kamiya, S., et al., "Analysis of purity of Clostridium difficile toxin A derived by affinity chromatography on immobilized bovine thyroglobulin", FEMS Microb Lett, 56:331-6 (1988).
Keighley, M.R.B., "Antibiotic-associated pseudomembranous colitis: pathogenesis and management", Drugs, 20:449-56 (1980).
Koike, K., et al., "Total Synthesis of Globotriaosyl-E and Z-Ceramides and Isoglobotriaosyl-E-Ceramide," Carbohy Res, 163:189-208 (1987).
Krivan, H.C., et al., "Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence .alpha.Gal(1-3).beta.Gal(1-4).beta.GlcNAc", Infect Immun, 53:573-81 (1986).
Krivan, H.C., et al., "Purification of Clostridium difficile toxin A by affinity chromatography on immobilized bovine thyroglobulin", Infect Immun, 55:1873-7 (1987).
Lee, R.T., et al., "Synthesis of 3-(2-Aminoethylthio) PropylGlycosides", Carbohy Res, 37: 193-201 (1974).
Lemieux, R.U., et al., "The properties of a `synthetic` antigen related to the blood-group Lewis A", J Am Chem Soc, 97:4076-83 (1975).
Lima, A.A., et al., "Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro," Infect Immun, 56:582-588 (1988).
Lyerly, D.M., et al., "Effects of Clostridium difficile toxins given intragastrically to animals," Infect Immun, 47:349-352 (1985).
Lyerly, D.M., et al., "Clostridium difficile: Its disease and toxins", Clin Microb Rev, 1:1-18 (1988).
Lyerly, D.M., "Epidemiology of Clostridium difficile disease", Clin Microb News, 15:49-53 (1993).
Okamoto, K., et al., "Glycosidation of Sialic Acid," Tetrahedron, 47:5835-5857 (1990).
Onderdonk, A.B., et al., "Comparative effects of clindamycin and clindamycin metabolites in the hamster model for antibiotic-associated colitis", J Antimicrob Chem, 8:383-93 (1981).
Paulsen, "Advances in Selective Chemical Syntheses of Complex Oligosaccharide", Angew Chem Int Ed Eng, 21:155-173 (1982).
Paulsen, H., "Syntheses von oligosaccharide-determinanten mit amid-spacer vom typ des T-antigens", Carbohy Res, 104:195-219 (1982).
Rana, S.S., et al., "Synthesis of Phenyl 2-Acetamido-2-Deoxy-3-O-.alpha. L-Fucopyranosyl-.beta.-D-Glucopyranoside and Related Compounds", Carbohy Res, 91:149-157 (1981).
Riegler, M., et al., J Clin Invest, 95:2004-2011 (1995).
Rolfe, R.D., "Binding kinetics of Clostridium difficile toxin A and B to intestinal brush border membranes from infant and adult hamste
Armstrong Glen D.
Heerze Louis D.
Fonda Kathleen K.
Synsorb Biotech Inc.
LandOfFree
Treatment of C. difficile toxin B associated conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of C. difficile toxin B associated conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of C. difficile toxin B associated conditions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-581240